Global Life Science Software Industry
Global Life Science Software Market to Reach $8. 5 Billion by 2027. Amid the COVID-19 crisis, the global market for Life Science Software estimated at US$5. 5 Billion in the year 2020, is projected to reach a revised size of US$8.
New York, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Life Science Software Industry" - https://www.reportlinker.com/p05957252/?utm_source=GNW
5 Billion by 2027, growing at aCAGR of 6.6% over the period 2020-2027. Cloud-based, one of the segments analyzed in the report, is projected to record 6.8% CAGR and reach US$5.3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the On-Premise segment is readjusted to a revised 6.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 6.2% CAGR
The Life Science Software market in the U.S. is estimated at US$1.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.5 Billion by the year 2027 trailing a CAGR of 6.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.2% and 5.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.We bring years of research experience to this 8th edition of our report. The 163-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
ArisGlobal LLC
Ducen IT
DXC Technology
EPAM Systems, Inc.
Fujitsu Ltd.
GE Healthcare
HCL Technologies Ltd.
Instem Group of Companies
Medidata Solutions, Inc.
Oracle Corporation
PDS
SAP SE
SAS Institute, Inc.
Signiant, Inc.
Veeva Systems, Inc.
Xybion Corporation
Read the full report: https://www.reportlinker.com/p05957252/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Global Competitor Market Shares
Life Science Software Competitor Market Share Scenario
Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Life Science Software Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027
Table 2: Life Science Software Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019
Table 3: Life Science Software Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027
Table 4: Cloud-based (Segment) World Market by Region/Country
in US$ Million: 2020 to 2027
Table 5: Cloud-based (Segment) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019
Table 6: Cloud-based (Segment) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
Table 7: On-Premise (Segment) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027
Table 8: On-Premise (Segment) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019
Table 9: On-Premise (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027
Table 10: Pharmaceutical (End-Use) Global Market Estimates &
Forecasts in US$ Million by Region/Country: 2020-2027
Table 11: Pharmaceutical (End-Use) Retrospective Demand
Analysis in US$ Million by Region/Country: 2012-2019
Table 12: Pharmaceutical (End-Use) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027
Table 13: Biotechnology (End-Use) Demand Potential Worldwide in
US$ Million by Region/Country: 2020-2027
Table 14: Biotechnology (End-Use) Historic Sales Analysis in
US$ Million by Region/Country: 2012-2019
Table 15: Biotechnology (End-Use) Share Breakdown Review by
Region/Country: 2012 VS 2020 VS 2027
Table 16: Other End-Uses (End-Use) Worldwide Latent Demand
Forecasts in US$ Million by Region/Country: 2020-2027
Table 17: Other End-Uses (End-Use) Global Historic Analysis in
US$ Million by Region/Country: 2012-2019
Table 18: Other End-Uses (End-Use) Distribution of Global Sales
by Region/Country: 2012 VS 2020 VS 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Life Science Software Market Share (in %) by Company: 2019 &
2025
Market Analytics
Table 19: United States Life Science Software Market Estimates
and Projections in US$ Million by Segment: 2020 to 2027
Table 20: Life Science Software Market in the United States by
Segment: A Historic Review in US$ Million for 2012-2019
Table 21: United States Life Science Software Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027
Table 22: United States Life Science Software Latent Demand
Forecasts in US$ Million by End-Use: 2020 to 2027
Table 23: Life Science Software Historic Demand Patterns in the
United States by End-Use in US$ Million for 2012-2019
Table 24: Life Science Software Market Share Breakdown in the
United States by End-Use: 2012 VS 2020 VS 2027
CANADA
Table 25: Canadian Life Science Software Market Estimates and
Forecasts in US$ Million by Segment: 2020 to 2027
Table 26: Canadian Life Science Software Historic Market Review
by Segment in US$ Million: 2012-2019
Table 27: Life Science Software Market in Canada: Percentage
Share Breakdown of Sales by Segment for 2012, 2020, and 2027
Table 28: Canadian Life Science Software Market Quantitative
Demand Analysis in US$ Million by End-Use: 2020 to 2027
Table 29: Life Science Software Market in Canada: Summarization
of Historic Demand Patterns in US$ Million by End-Use for
2012-2019
Table 30: Canadian Life Science Software Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
JAPAN
Table 31: Japanese Market for Life Science Software: Annual
Sales Estimates and Projections in US$ Million by Segment for
the Period 2020-2027
Table 32: Life Science Software Market in Japan: Historic Sales
Analysis in US$ Million by Segment for the Period 2012-2019
Table 33: Japanese Life Science Software Market Share Analysis
by Segment: 2012 VS 2020 VS 2027
Table 34: Japanese Demand Estimates and Forecasts for Life
Science Software in US$ Million by End-Use: 2020 to 2027
Table 35: Japanese Life Science Software Market in US$ Million
by End-Use: 2012-2019
Table 36: Life Science Software Market Share Shift in Japan by
End-Use: 2012 VS 2020 VS 2027
CHINA
Table 37: Chinese Life Science Software Market Growth Prospects
in US$ Million by Segment for the Period 2020-2027
Table 38: Life Science Software Historic Market Analysis in
China in US$ Million by Segment: 2012-2019
Table 39: Chinese Life Science Software Market by Segment:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 40: Chinese Demand for Life Science Software in US$
Million by End-Use: 2020 to 2027
Table 41: Life Science Software Market Review in China in US$
Million by End-Use: 2012-2019
Table 42: Chinese Life Science Software Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027
EUROPE
Market Facts & Figures
European Life Science Software Market: Competitor Market Share
Scenario (in %) for 2019 & 2025
Market Analytics
Table 43: European Life Science Software Market Demand Scenario
in US$ Million by Region/Country: 2020-2027
Table 44: Life Science Software Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019
Table 45: European Life Science Software Market Share Shift by
Region/Country: 2012 VS 2020 VS 2027
Table 46: European Life Science Software Market Estimates and
Forecasts in US$ Million by Segment: 2020-2027
Table 47: Life Science Software Market in Europe in US$ Million
by Segment: A Historic Review for the Period 2012-2019
Table 48: European Life Science Software Market Share Breakdown
by Segment: 2012 VS 2020 VS 2027
Table 49: European Life Science Software Addressable Market
Opportunity in US$ Million by End-Use: 2020-2027
Table 50: Life Science Software Market in Europe: Summarization
of Historic Demand in US$ Million by End-Use for the Period
2012-2019
Table 51: European Life Science Software Market Share Analysis
by End-Use: 2012 VS 2020 VS 2027
FRANCE
Table 52: Life Science Software Market in France by Segment:
Estimates and Projections in US$ Million for the Period
2020-2027
Table 53: French Life Science Software Historic Market Scenario
in US$ Million by Segment: 2012-2019
Table 54: French Life Science Software Market Share Analysis by
Segment: 2012 VS 2020 VS 2027
Table 55: Life Science Software Quantitative Demand Analysis in
France in US$ Million by End-Use: 2020-2027
Table 56: French Life Science Software Historic Market Review
in US$ Million by End-Use: 2012-2019
Table 57: French Life Science Software Market Share Analysis:
A 17-Year Perspective by End-Use for 2012, 2020, and 2027
GERMANY
Table 58: Life Science Software Market in Germany: Recent Past,
Current and Future Analysis in US$ Million by Segment for the
Period 2020-2027
Table 59: German Life Science Software Historic Market Analysis
in US$ Million by Segment: 2012-2019
Table 60: German Life Science Software Market Share Breakdown
by Segment: 2012 VS 2020 VS 2027
Table 61: Life Science Software Market in Germany: Annual Sales
Estimates and Forecasts in US$ Million by End-Use for the
Period 2020-2027
Table 62: German Life Science Software Market in Retrospect in
US$ Million by End-Use: 2012-2019
Table 63: Life Science Software Market Share Distribution in
Germany by End-Use: 2012 VS 2020 VS 2027
ITALY
Table 64: Italian Life Science Software Market Growth Prospects
in US$ Million by Segment for the Period 2020-2027
Table 65: Life Science Software Historic Market Analysis in
Italy in US$ Million by Segment: 2012-2019
Table 66: Italian Life Science Software Market by Segment:
Percentage Breakdown of Sales for 2012, 2020, and 2027
Table 67: Italian Demand for Life Science Software in US$
Million by End-Use: 2020 to 2027
Table 68: Life Science Software Market Review in Italy in US$
Million by End-Use: 2012-2019
Table 69: Italian Life Science Software Market Share Breakdown
by End-Use: 2012 VS 2020 VS 2027
UNITED KINGDOM
Table 70: United Kingdom Market for Life Science Software:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2020-2027
Table 71: Life Science Software Market in the United Kingdom:
Historic Sales Analysis in US$ Million by Segment for the
Period 2012-2019
Table 72: United Kingdom Life Science Software Market Share
Analysis by Segment: 2012 VS 2020 VS 2027
Table 73: United Kingdom Demand Estimates and Forecasts for
Life Science Software in US$ Million by End-Use: 2020 to 2027
Table 74: United Kingdom Life Science Software Market in US$
Million by End-Use: 2012-2019
Table 75: Life Science Software Market Share Shift in the
United Kingdom by End-Use: 2012 VS 2020 VS 2027
REST OF EUROPE
Table 76: Rest of Europe Life Science Software Market Estimates
and Forecasts in US$ Million by Segment: 2020-2027
Table 77: Life Science Software Market in Rest of Europe in US$
Million by Segment: A Historic Review for the Period 2012-2019
Table 78: Rest of Europe Life Science Software Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027
Table 79: Rest of Europe Life Science Software Addressable
Market Opportunity in US$ Million by End-Use: 2020-2027
Table 80: Life Science Software Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by End-Use for
the Period 2012-2019
Table 81: Rest of Europe Life Science Software Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
ASIA-PACIFIC
Table 82: Life Science Software Market in Asia-Pacific by
Segment: Estimates and Projections in US$ Million for the
Period 2020-2027
Table 83: Asia-Pacific Life Science Software Historic Market
Scenario in US$ Million by Segment: 2012-2019
Table 84: Asia-Pacific Life Science Software Market Share
Analysis by Segment: 2012 VS 2020 VS 2027
Table 85: Life Science Software Quantitative Demand Analysis in
Asia-Pacific in US$ Million by End-Use: 2020-2027
Table 86: Asia-Pacific Life Science Software Historic Market
Review in US$ Million by End-Use: 2012-2019
Table 87: Asia-Pacific Life Science Software Market Share
Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and
2027
REST OF WORLD
Table 88: Rest of World Life Science Software Market Estimates
and Forecasts in US$ Million by Segment: 2020 to 2027
Table 89: Rest of World Life Science Software Historic Market
Review by Segment in US$ Million: 2012-2019
Table 90: Life Science Software Market in Rest of World:
Percentage Share Breakdown of Sales by Segment for 2012, 2020,
and 2027
Table 91: Rest of World Life Science Software Market
Quantitative Demand Analysis in US$ Million by End-Use: 2020 to
2027
Table 92: Life Science Software Market in Rest of World:
Summarization of Historic Demand Patterns in US$ Million by
End-Use for 2012-2019
Table 93: Rest of World Life Science Software Market Share
Analysis by End-Use: 2012 VS 2020 VS 2027
IV. COMPETITION
Total Companies Profiled: 31
Read the full report: https://www.reportlinker.com/p05957252/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001